NCT06256224View on ClinicalTrials.gov

Toripalimab Combined With Definitive CCRT for LACC Patients

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Cervical CancerChemoradiotherapyImmunotherapy
Interventions
DRUG

Toripalimab

Toripalimab combined with CCRT

RADIATION

CCRT

CCRT includes cisplatin (40 mg/m2, once a week for 5 weeks), radiotherapy (45-50.4Gy/25-28Fx, 5 fractions a week, followed by brachytherapy 24-30Gy/3-5Fx)

Trial Locations (1)

200000

RECRUITING

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER